tetano
Editor, Senior Moderator
Virol J
. 2023 Apr 12;20(1):67.
doi: 10.1186/s12985-023-02015-0.
Influenza vaccine effectiveness in patients hospitalized with severe acute respiratory infection in Lithuania during the 2019-2020 influenza season: a test negative case - control study
Roberta Vaikutyte[SUP] 1 [/SUP], Monika Kuliese[SUP] 2 [/SUP], Aukse Mickiene[SUP] 2 [/SUP], Ligita Jancoriene[SUP] 3 4 [/SUP], Birute Zablockiene[SUP] 3 4 [/SUP], Giedre Gefenaite[SUP] 2 5 [/SUP]; Study group
Affiliations
Abstract
Background: Influenza is a contagious viral airborne disease that adds to the clinical and economic burden on the healthcare system. It could be prevented substantially by seasonal influenza vaccination. Seasonal influenza vaccine effectiveness (SIVE) varies a lot and should therefore be monitored. This report aims to update age-stratified SIVE estimates among patients hospitalized due to severe acute respiratory infection (SARI) during the 2019-2020 influenza season.
Methods: We performed a test-negative case-control study between December 2019 and April 2020 influenza season. We estimated SIVE and its 95% confidence intervals (95% CI) with logistic regression as (1-odds ratio)*100%. The models were adjusted for covariates that changed the unadjusted SIVE by ≥ 10%.
Results: Among 84 participants, 32 (38.1%) were influenza positive, mostly with A(H1N1)pdm09 (25 cases; 78.1%). SIVE against any influenza adjusted for age and heart disease was 39.2% (95% CI: -119.3%, 83.1%). Age-stratified point estimates adjusted for heart diseases indicated different SIVE, and were 64.0% (95% CI: -309.2%, 96.8%) and 21.6% (95% CI: -252.2%, 82.6%) for 18-64 and ≥ 65 year-old participants, respectively.
Conclusions: The point estimates suggested low to moderate SIVE against any influenza among hospitalized 18-64-year-old SARI participants, while low estimates were found in the ≥ 65-year-old group. Although broad SIVE confidence intervals indicate a small sample size and therefore the results can serve only as indicatory, they are in line with the estimates reported by other studies during the 2019-2020 season.
Keywords: Hospital surveillance; Influenza; Test-negative design; Vaccine effectiveness.
. 2023 Apr 12;20(1):67.
doi: 10.1186/s12985-023-02015-0.
Influenza vaccine effectiveness in patients hospitalized with severe acute respiratory infection in Lithuania during the 2019-2020 influenza season: a test negative case - control study
Roberta Vaikutyte[SUP] 1 [/SUP], Monika Kuliese[SUP] 2 [/SUP], Aukse Mickiene[SUP] 2 [/SUP], Ligita Jancoriene[SUP] 3 4 [/SUP], Birute Zablockiene[SUP] 3 4 [/SUP], Giedre Gefenaite[SUP] 2 5 [/SUP]; Study group
Affiliations
- PMID: 37046288
- PMCID: PMC10091321
- DOI: 10.1186/s12985-023-02015-0
Abstract
Background: Influenza is a contagious viral airborne disease that adds to the clinical and economic burden on the healthcare system. It could be prevented substantially by seasonal influenza vaccination. Seasonal influenza vaccine effectiveness (SIVE) varies a lot and should therefore be monitored. This report aims to update age-stratified SIVE estimates among patients hospitalized due to severe acute respiratory infection (SARI) during the 2019-2020 influenza season.
Methods: We performed a test-negative case-control study between December 2019 and April 2020 influenza season. We estimated SIVE and its 95% confidence intervals (95% CI) with logistic regression as (1-odds ratio)*100%. The models were adjusted for covariates that changed the unadjusted SIVE by ≥ 10%.
Results: Among 84 participants, 32 (38.1%) were influenza positive, mostly with A(H1N1)pdm09 (25 cases; 78.1%). SIVE against any influenza adjusted for age and heart disease was 39.2% (95% CI: -119.3%, 83.1%). Age-stratified point estimates adjusted for heart diseases indicated different SIVE, and were 64.0% (95% CI: -309.2%, 96.8%) and 21.6% (95% CI: -252.2%, 82.6%) for 18-64 and ≥ 65 year-old participants, respectively.
Conclusions: The point estimates suggested low to moderate SIVE against any influenza among hospitalized 18-64-year-old SARI participants, while low estimates were found in the ≥ 65-year-old group. Although broad SIVE confidence intervals indicate a small sample size and therefore the results can serve only as indicatory, they are in line with the estimates reported by other studies during the 2019-2020 season.
Keywords: Hospital surveillance; Influenza; Test-negative design; Vaccine effectiveness.